Accu-Chek® CONNECT at School (CATS) Pediatric Study

Inclusion Criteria:

- Children or adolescents, aged 6 to 18 years

- Diagnosis of T1D for at least 3 months

- Currently managed with insulin Multiple Daily Injection (MDI) therapy

- Attending full-day school schedule in Grade K through 12

- Able to provide SMBG data minimum of one month prior to study start

- Currently using a compatible Smartphone with ability to download the Accu-Chek®
CONNECT System App accordingly OR ability to utilize Smartphone and Accu-Chek® CONNECT
System App as provided for use in study

- Adolescents (18 years) with diabetes provide written informed consent

- Children 7 to 17 years to provide age-appropriate child assent

- Parent/caregiver currently using a compatible Smartphone with ability to receive Short
Message Service/Multimedia Messaging Service (SMS/MMS) messages

- Able to read/write in English and comply with study procedures, including provision of
self-monitoring blood glucose (SMBG) data at least 1 month prior to the study

Exclusion Criteria:

- Current or planned use of continuous subcutaneous insulin infusions during the study
period

- Use of continuous glucose monitoring or a remote data-sharing system/device (i.e.
NightScout, DexCom Share, Medtronic Connect) during the study

- Pregnancy

- Clinically significant medical condition(s) such as anemia, major organ system
disease, infection, psychosis, or cognitive impairment

- Requirement for chronic steroids, immunomodulatory medication, or chemotherapy in
adrenal suppressive doses

- Visual impairment preventing use of the Accu-Chek® CONNECT system

- Parent/caregiver is an investigator, general practitioner, practice staff, pharmacist,
research assistant, or other staff or relative of those directly involved in the study